SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2022

Steady Start to 2022; FY 2022 Constant Currency Revenue Growth Guidance Reaffirmed BOSTON, United States and LAUSANNE, Switzerland, May 10, 2022 — SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today reported financial results for the first quarter ended March 31, 2022. Recent Highlights Revenue for the first quarter of 2022 was $10.9 million, …

SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2022 Read More »

SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directorsm

BOSTON, United States and LAUSANNE, Switzerland – May 5, 2022 – SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, today announced the nomination of Jean-Michel Cosséry to its Board of Directors. The Board of Directors will propose the appointment of Mr. Cosséry as a member of the Board of Directors and a member of the Compensation Committee …

SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directorsm Read More »

NETGUARDIANS IS SELECTED BY LUKB TO FURTHER STRENGTHEN FRAUD PREVENTION

Yverdon-les-Bains, 3 May, 2022: Award-winning Swiss fintech NetGuardians, renowned for its enterprise risk platform for combatting financial fraud, today announced it has been selected by Luzerner Kantonalbank AG (LUKB) to further enhance its fraud-prevention systems. LUKB is implementing NetGuardians’ AI-based fraud-mitigation software as part of its defenses against payment fraud. The software builds up accurate profiles …

NETGUARDIANS IS SELECTED BY LUKB TO FURTHER STRENGTHEN FRAUD PREVENTION Read More »

HAYA Therapeutics Announces Funding from Swiss Innovation Agency Supporting Research Collaborations for Long Non-Coding RNA Therapies

New research partnerships with world-leading institutions University of Bern, University Hospital of Bern and Lausanne University Hospital Non-dilutive funding will enable the development of therapies targeting lncRNA for cardiomyopathy and squamous cell carcinoma LAUSANNE, Switzerland and SAN DIEGO – May 3, 2022 — HAYA Therapeutics, SA, a company developing precision medicines that target tissue and cell-specific long non-coding …

HAYA Therapeutics Announces Funding from Swiss Innovation Agency Supporting Research Collaborations for Long Non-Coding RNA Therapies Read More »

SPACEBEL AND CYSECSPACEBEL AND CYSEC

The European Space Agency (ESA) awarded a contract to Spacebel (Prime contractor) and CYSEC (subcontractor) to test the secure deployment of the latest generation of European mission control software on a satellite simulator.  Cyber threats on satellite systems are more and more of a concern and are becoming a reality for satellite operators, as the recent attack …

SPACEBEL AND CYSECSPACEBEL AND CYSEC Read More »

SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM™ Platform

BOSTON, United States and LAUSANNE, Switzerland – April 26, 2022 – SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, has reached the milestone of one million genomic profiles analyzed by its SOPHiA DDM™ Platform, securing its position as one of the largest knowledge sharing platforms connecting thousands of healthcare professionals and researchers across more than 70 countries. Founded …

SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM™ Platform Read More »

The Philippines’ first neobank Tonik chooses NetGuardians and Finastra as fraud mitigation partner

The Philippines’ first neobank Tonik chooses NetGuardians and Finastra as fraud mitigation partner We are delighted to announce that Tonik, the first neobank to be granted a digital banking license in the Philippines, has selected NetGuardians and Finastra’s AI-based fraud mitigation solution to help reduce fraud by preventing fraudulent payments in real time. The solution will …

The Philippines’ first neobank Tonik chooses NetGuardians and Finastra as fraud mitigation partner Read More »

NETGUARDIANS PARTNERS WITH CYBERA TO FIGHT FINANCIAL FRAUD

Yverdon-les-Bains, 13 April 2022: Award-winning Swiss FinTech NetGuardians, renowned for its enterprise risk platform for combatting bank fraud, today announced it has entered into a partnership with CYBERA, the global fraud complaints and real-time cybercrime data sharing platform. NetGuardians is a leading fraud-prevention software provider, using artificial intelligence to build accurate customer profiles against which every …

NETGUARDIANS PARTNERS WITH CYBERA TO FIGHT FINANCIAL FRAUD Read More »